MedTrace Logo

The VIRTUE Post Marketing Surveillance Registry

NCT01213589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-12-11

Study results available
· View outcomes & findings →

Summary

The purpose of this post-market release registry is to collect additional information concerning safety, performance and health economic data with respect to the Medtronic VALIANT Thoracic Stent Graft with the Xcelerant Delivery System in the treatment of descending thoracic aortic dissections.

Conditions

  • Aortic Dissection

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • M. Thompson, Prof. · St George's Hospital

  • D. Gasparini, Dr. · Azienda Ospedaliera "Santa Maria della Misericordia"

  • R. Fattori, Prof. · Ospedale Sant'Orsola Malpighi

  • P. Cao, Dr. · Unità di Chirurgia Vascolare, Ospedale R. Silvestrini

  • G. Garzón, Dr. · Hospital Universitario La Paz

  • E. Ros, Prof. · Hospital Clínico Universitario San Cecilio

  • B. Rylski, Dr. · Universitätsklinikum Freiburg

  • S. Huptas, Dr. · Universitätsklinikum Essen

  • I. Degrieck, Dr. · Onze-Lieve-Vrouw Ziekenhuis

  • D. Dai-DoDo, Prof. · Universitätsspital Bern, Inselspital

  • H. Roos, Dr. · Sahlgrenska University Hospital

  • R. Heijmen, Dr. · St. Antonius Hospital

  • N. Cheshire, Prof. · St Mary's NHS Trust

  • C. Nienaber, Dr · University School of Medicine Rostock

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01213589 on ClinicalTrials.gov